Skip to main content
Download PDF
Download ePub

Sex-dependent vulnerability for Wistar rats model following intranasal instillation with Klebsiella pneumoniae ATCC 43816 causing lobar pneumonia

Pneumonia volume 16, Article number: 5 (2024) Cite this article

Abstract

Background

Klebsiella pneumoniae has become one of the major threats to public health as it causes nosocomial and community-acquired infections like lobar pneumonia. This infection causes acute inflammation in the lung, characterized by the recruitment of polymorphonuclear cells, generating free radicals, and decreasing the endogenous antioxidant balance system. Many experimental studies have focused on the induction, progression and resolution of infection up to its peak, but these documented processes remain highly random and their sex dependence un-elicited. These fluctuations of physiopathological parameters would impact disease progression depending on the animal’s model and bacterial strain used. The present study investigated the sex-dependent vulnerability of Wistar rats to K. pneumoniae ATCC 43816 lobar pneumonia induced by the intranasal instillation method.

Methods

Experimental pneumonia was induced by K. pneumoniae ATCC 43816 in male and female Wistar rats following intranasal instillation. The physiopathogenesis of the disease was studied by bacteriological and histopathological exams, histomorphometric analysis of the blood and/or lung tissue, and body weight loss in infected animals. In addition, the overall severity of lesions was determined by the total score obtained by averaging the individual scores from the same group of animals.

Results

The K. pneumoniae ATCC 43816 strain showed inoculation dose-, incubation time of the disease- and sex-dependent- differences in its ability to induce lobar pneumonia. Evaluation of different parameters showed that the disease peaked on day 15 post-inoculation, with more pathogenic effects on female rats. This observed sex-dependence difference in Wistar rats was mainly highlighted by the determined lethal dose 50 (LD50), bacterial load count in whole blood and lung tissues, body weight loss, inflammatory granulomas forming and diffuse alveolar damages. The pathogenicity was confirmed by scoring the severity of pathologic lesions of lung tissues.

Conclusions

The results obtained highlighted the gender-dependency in the physiopathogenesis processes of K. pneumoniae ATCC 43816 induced-lobar pneumonia, in Wistar rats. Female Wistar rats’ susceptibility is useful in studying pathology and in preclinical trial investigations of new treatments for infectious pneumonia.

Background

Pneumonia is defined as an acute inflammation of the parenchymal structure of the lung [1] and is characterized by increased infiltration of neutrophils, leukocytes, or polymorphonuclear cells, generating free radicals, and decreasing the endogenous antioxidant balance system due to the entrance of infectious agent [2, 3]. On the cell structure of the causative agents, it can be classified as the viral, parasite, fungal or bacterial origin with the Gram-negative preponderance as Haemophilus influenzae, Pseudomonas aeruginosa and Klebsiella pneumoniae in nosocomial pneumonia [4]. Pneumonia caused by K. pneumoniae bacteria is characterized by a rapid and progressive clinical course which is often complicated by multi-lobular involvement and lung abscesses [2]. Based on the lungs’ anatomical site of infection, this type of pneumonia can be classified as lobar pneumonia, bronchial pneumonia or acute interstitial pneumonia. Likewise, it can also be classified on the basis of its clinical severity as “no pneumonia”, “pneumonia” or “severe pneumonia” [1, 4].

Worldwide, pneumonia epidemiological data have shown that it provokes death more than any other infectious disease and highlights a slight decrease in prevalence as a result of existing therapies [5, 6]. According to the WHO, data’s from the last two decades on the disease have shown that males have a higher incidence than females [7].

Several studies have investigated sex disparities in the resistance and susceptibility to infection-induced lung injury or the severity of the disease. However, these studies showed a high degree of sex-related variability in pathophysiological processes as reflected in immune and hormonal function in humans and animals [8].

For instance, some studies have shown that males typically exhibit weaker responses compared to females when exposed to infectious pneumonia, exhibiting better resistance to the disease [9]. On the opposite, a more integrative review of the literature on epidemiological data between 2000 – 2020 reveals a higher susceptibility of male subjects to develop infectious pneumonia [6, 7]. Other studies have shown sex-dependent susceptibility and severity of the disease in several animal models of respiratory infection [8,9,10]. Thus, in animal models of respiratory infection, the severity of the disease could rather be a function of the animal model and microbial strains used in correlation with sex parameters [8].

To date, to the best of our knowledge, very few data are available on the pathogenesis of the induced-respiratory infection in the Wistar rat model. Furthermore, very conflicting data exist regarding the sex-dependent vulnerability of the pathogenesis of K. pneumoniae. In addition, many other factors such as the method of induction of the disease, the inducting doses of the pathogenic agent, the incubation time, and the severity of the pathology or the individual resistance to the pathogen, are known to affect the pathogenic profile of K. Pneumoniae. Therefore, determining the existing correlations between the sus-mentioned physiopathological conditions could be of great interest in the optimization of preclinical trials on the Wistar rat model for pulmonary infection diseases.

Thus, this study sets out to evaluate the sex-dependent vulnerability of Wistar rats to K. pneumoniae ATCC 43816 induced lobar pneumonia by the intranasal instillation.

Methods

Bacterial strain

The strain of K. pneumoniae ATCC 43816, (obtained by the Head of Bacteriology Laboratories of the University Teaching Hospital of Yaoundé, Cameroon) was used in the study. The strain was identified as K. pneumoniae using standard procedures [11].

Bacterial inoculum

Bacterial strains maintained on the Mueller Hinton Agar slant were grown in static culture in Mueller Hinton broth at 37 ºC for 18 h. Microorganisms were harvested by centrifugation at 2348 g for 15 min, washed three times, and suspended in phosphate-buffered saline (PBS, 0.2 M pH 7.2) to the desired concentration [12].

Animal housing and acclimation

Wistar rats strain acquired from the Animal House of the Department of Animal Biology and Physiology, University of Yaoundé I, aged 6–8 weeks and weighing 140 ± 10 g at the pneumonia induction onset, were used in this study. The animals were allotted in groups of 6 per cage and housed at 25 ± 3 °C under a 12 h light/dark cycle, except during the designated experimental procedures. They were fed on standard antibiotic-free synthetic feed (Animal Foods, Cameroon). All the experiments were carried out at the Multidisciplinary Laboratory of the University of Yaoundé I. The preclinical experimentation got ethical clearance from the Ethical committee of the University of Yaoundé I ID: 443/UYI/FMSB/VDRC/DAASR/CSD.

Standardization of the bacterial inoculum for induction of pneumonia

The optimal K. pneumoniae dose required for establishing pneumonia in rats was standardised prior to studying the course of pneumonia using McFarland turbidity standard 0.5. To this end, doses ranging from 1.5 × 105 to 1.5 × 108 CFU/mL were administered intranasally. Experimentally, 240 Wistar rats (M/F; 1:1) were used to standardize the pneumonia induction. The grouping of animals is represented in Table 1.

Table 1 Repartition of animal for the study
Full size table

Each test group containing female and male Wistar rats was infected with an appropriate dose of K. pneumoniae inoculum and animals sacrificed respectively on days 0, 5, 10 and 15 post-inoculations (PI) to count for bacterial load in the blood and lung tissue to determine the infection rate.

The control group used as the not-induction model was also sacrificed on the same days as the tested groups. The inoculum dose that gave the infection rate of 100 per cent, without causing any mortality was taken as the infectious optimal dose [13].

Induction of pneumonia by intranasal instillation

For intranasal instillation of the bacterial inoculum, the method of Held et al. [13] was employed with slight modifications [2, 14]. Briefly, animals were pre-treated for 3 days by administration of Penicillin (400 000 IU/kg/day) under anaesthesia with Pentobarbital sodium (30 mg/kg intraperitoneal administration) to prevent secondary infections. After a recovery period of 2 weeks, rats were anaesthetized by inhalation of CO2 (Medibest, Yaoundé, Cameroon), and administered intranasally with 50 μL of K. pneumoniae inoculum or the physiological water while being held in a vertical position. This procedure was performed daily for 15 days. After inoculation, rats regained consciousness and their general state of health and body weight were monitored daily. Each group of rats were sacrificed by disruption of the jugular vein on days 0, 5, 10 and 15 post-inoculations. Whole blood was collected through the jugular vein and immediately diluted 1/10 in aseptic conditions to count K. pneumoniae colonies. Lungs were also removed aseptically and divided into two parts. The lungs were cut longitudinally in equal parts. The outer part of the lung was also attributed to the count of K. pneumoniae cells. The inner part was dedicated to histomorphopathological analyses.

Bacteriological examination

1.0 mL of whole blood was prepared by making a 1/10 dilution of the collected blood in sterile PBS (0.2 M, pH 7.2). Concerning the lung tissue, it was sectioned into two halves. The outer part of the lung (1.0 g) was placed in a sterile tube, weighed and crushed. The tissue was homogenized in a Corning glass homogenizer with 9.0 mL of sterile PBS (0.2 M; pH 7.2). Serial dilutions of blood and homogenate lung solutions were plated on MacConkey agar plates (Himedia, India) in triplicate. Plates were incubated at 37 ºC for 24 h, and K. Pneumoniae colony counts were determined.

Histopathological and histomorphometric analysis

The inner part of each lung was fixed for 48 h at room temperature in neutralized 10% buffered formalin, routinely processed and embedded in paraffin [15]. Paraffin-embedded lung sections were haematoxylin and eosin (Sigma Aldrich, France) stained to highlight the structure of lung parenchyma and monitor their inflammation degree [16]. These sections were observed under an Olympus microscope (Olympus U-TV 0.63 × C; SN 9L01588 T2, Tokyo; Japan).

In addition, graduation of the severity of pathological lesions was performed using a section of each animal lung on a semi-quantitative scale of 0 to 4 (Table 2), according to the modified method of Yadav et al. [12]. A total score indicative of the overall severity of lesions was determined by averaging the individual scores from the same group of animals. The Image.J software version 1.53 was used to analyse the histomorphometric data.

Table 2 Semi-quantitative scores for grading the severity of pathologic lesions of the lungs
Full size table

Statistical analysis

Results (n = 6) are expressed as Mean ± SD. The analysis was done by applying the analysis of variance (ANOVA), followed by Dunnett’s test to compare K. pneumoniae colony counts, severity scores of pneumonic lesions in the lung tissues, histomorphometric measurements of inflammatory granulomas areas and body weight evolution on the different days post-inoculation and/or in animal groups. The graphical representation of the data was performed using the Graph Pad Prism 9.3.1 (350) software for Windows (Graph Pad Software Inc., La Jolla California, USA). The difference was taken to be statistically significant at p < 0:05.

Results

Standardization of lung infection caused by K. pneumoniae in rat model

Signs of morbidity and lethal dose 50 (LD50) of K. pneumoniae ATCC 43816 strain

In the first set of experiments, we determined the doses that are able to induce lobar pneumonia by instilling a wide log range of K. pneumoniae inoculum (1.5 × 105 to 1.5 × 108 CFU/mL) for 15 days. Thus, the pathogen doses inducing a stable non-mortal infection were determined to lie from 1.5 × 106 to 1.5 × 108 CFU/mL depending on the gender. However, it should be noticed that these doses are the onset of persistent diarrhoea, severe coughing and chills from day 10, post-infection in female rats, whereas in male rats, only the dose of 1.5 × 108 CFU/mL produced the same clinical signs. The results from these experiments allowed us to evaluate the LD50 of K. pneumoniae ATCC 43816 strain at approximately 1.5 × 108 CFU/mL for female rats, all deaths occurring between day 10 and day 15. Considering that male rats showed any mortality at the studied doses, the LD50 can be extrapolated to be higher than 1.5 × 108 CFU/mL.

K. pneumoniae load in blood and lung tissue

Bacterial loads in the blood and lungs in female and male Wistar rats were assessed for the sacrifice day (day 0) and the following days 5, 10, and 15 post-inoculations with 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL of K. pneumoniae. The results showed no bacteria detection in blood samples on day 5 after inoculation of 1.5 × 105 and 1.5 × 106 UFC/mL, (p > 0.05) both in male and female rats (Fig. 1A–B). However, the infected groups of 1.5 × 107 and 1.5 × 108 UFC/mL of K. pneumoniae, indicated bacterial loads of respectively 3.03 log10 (± 0.16) and 3.21 log10 (± 0.05) bacteria/mL in male rat blood (p < 0.05). The bacterial loads for the doses of 1.5 × 107 and 1.5 × 108 UFC/mL were 3.05 log10 (± 0.01) and 3.7 log10 (± 0.04) bacteria/mL respectively, in female rat blood (p < 0.05). On days 10 and 15 PI, K. pneumoniae colonies were detected in blood samples at all doses, indicating that these doses induce bacteraemia, after 15 days PI (p < 0.05). We noted a proportional evolution between the K. pneumoniae load in blood and the tested doses of inoculated bacteria in both male and female rats.

Fig. 1
figure 1

K. pneumoniae ATCC 43816 count in the blood and lung tissues of Wistar rats. Bacterial load in the blood (A: males and B: females) and lungs (C: males and D: females) of daily up to day 15 instillation of K. pneumoniae at 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL doses in Wistar rats. All results were mean ± SD of six animals per group. Bacterial count evolution was analysed using Dunnett’s post-test (*: p < 0.05; **: p < 0.01; ***: p < 0.001); K. pneumoniae ATCC 43816 infected groups at 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL doses vs not-infected group

Full size image

Bacteriological analysis of the lung tissue homogenates showed that K. pneumoniae reached the outer part of the lungs on day 5 after inoculation with bacterial concentrations ranging from 3.08 log10 (± 0.27) to 5.07 log10 (± 0.07) bacteria/mL and 3.45 log10 (± 0.03) to 5.19 log10 (± 0.05) bacteria/mL for male and female rats respectively (Fig. 1C–D). The bacterial loads regularly increased during the next 15 days PI, reaching 5.43 log10 (± 0.04), 8.52 log10 (± 0.03), 9.36 log10 (± 0.08), and 10.36 log10 (± 0.19) bacteria/mL respectively for the doses of 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL in female rats (p < 0.01). A similar evolution of K. pneumoniae load in lung tissue was observed in male rats (p < 0.01).

Inflammatory granuloma forming and histomorphometric data

Inflammatory granuloma forming

Histopathology of the lungs showed a more diffuse and patchy accumulation of inflammatory cells within the alveolar space along with the infiltrates noted in all lung sections of infected rats (Fig. 2A − B). No exudate was observed in none-infected rats. In addition, the alveoli were found to be intact with undamaged lung parenchyma in not-infected rats.

Fig. 2
figure 2

Photomicrographs of lung parenchyma of male (A) and female (B) Wistar rats. The inflammatory granulomas (IG: in yellow) visualised at days 0, 5, 10 and 15 post-inoculations in the pathologic lungs due to the recruitment of the polymorphonuclear cells by diapedesis towards the inflamed conjunctive tissues of pulmonary parenchyma and showing the abscess formation and destruction of alveoli in the severe stage after K. pneumoniae ATCC 43816 infection at 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL doses. (Haematoxylin & Eosin colouration X40). Br: Bronchiole; Ln: Lymphatic nodules; IG: Inflammatory granulomas; AV: Pulmonary alveoli and PA: Pulmonary arteriole

Full size image

Histopathological analysis of the lung tissue represented in Fig. 2B revealed that following 10 days of exposure to K. pneumoniae ATCC 43816, female rats developed pneumonia (score 1–4; p < 0.001), characterized by cellular infiltrate composed of neutrophils and a few macrophages with abscess formation and destruction of alveoli. The histopathology of female Wistar rats sacrificed on day 15 PI, for all bacterial concentrations, showed installing lobar pneumonia and macrophages dominating (score 3–4; p < 0.001) in the affected areas (Fig. 2B). Interestingly, in male rats infected with K. pneumoniae ATCC 43816 at 1.5 × 105 CFU/mL, the pneumonia infection was resorbed (score + 1; p > 0.05) at day 15, and characterized by the residual presence of leukocytes in the inflamed lung tissue (Fig. 2A). Similar to female rats, only the 1.5 × 108 CFU/mL dose had shown a pattern of pneumonia infection with the intermediate score (score + 3; p < 0.01) from day 5 (Fig. 3A–B). The other K. pneumoniae ATCC 43816 doses have shown inconsistent infection patterns.

Fig. 3
figure 3

Quantitative scores for grading the severity of pneumonic lesions in lung parenchyma of Wistar rats. Scores of parenchymal lesions of the lungs in male (A) and female (B) Wistar rats infected by the K. pneumoniae ATCC 43816 doses (1.5 × 105, 1.5 × 106, 1.5 × 107 or 1.5 × 10.8 CFU/mL) on days 0, 5, 10 and 15 PI. All results were mean ± SD of six animals per group. Severity scores were analysed using Dunnett’s post-test (*: p < 0.05; **: p < 0.01; ***: p < 0.001); Days post-inoculation 5, 10 and 15 vs Day 0

Full size image

Histomorphometric data

The histomorphometric analysis of inflammatory granuloma areas of lung parenchyma of female Wistar rats also showed that the inflammatory granuloma surfaces are roughly proportional to the K. pneumoniae ATCC 43816 inoculated dose, incubation time and post-inoculated bacteria load (Fig. 4B).

Fig. 4
figure 4

Histomorphometric measurements of inflammatory granulomas areas of lung tissues of Wistar rats. Measures (μm2) of parenchymal lesions surfaces of inflamed lungs of male (A) and female (B) Wistar rats showing the significant difference between each dose (1.5 × 105, 1.5 × 106, 1.5 × 107 or 1.5 × 10.8 CFU/mL) on days 0, 5, 10 and 15 PI. All results were mean ± SD of six animals per group. Histomorphometric measurements were analysed using Dunnett’s post-test (*: p < 0.05; **: p < 0.01; ***: p < 0.001); Days post-inoculation 5, 10 and 15 vs Day 0

Full size image

Histomorphometric data analysis of inflammatory granulomas surfaces of the male rat lungs at the dose of 1.5 × 108 CFU/mL showed that the spread of infection after days 0, 5, 10 and 15 PI was similar (p < 0.001) to that of female rats (Fig. 4A–B). In contrast in the other groups of male rats, the study has shown that the disease evolves in a jagged pattern for doses less than 1.5 × 108 CFU/mL. We noted a significant regression of inflammatory granulomas of 55.44% for infecting dose of 1.5 × 105 CFU/mL (p < 0.001) and a slight of 14.95% for 1.5 × 106 CFU/mL dose (p > 0.05) at day 15 compared to day 10 PI. In addition, a non-significant decrease of 39.33% was observed from day 5 to day 10 PI with a dose of 1.5 × 107 CFU/mL (p > 0.05). It was subsequently; followed by a significant increase in inflammatory granuloma area of 75.69% (p < 0.001) observed afterwards from day 10 to day 15 for 1.5 × 107 CFU/mL dose. The proportion of pro-inflammatory cells decreased from day 5 to day 10, at the dose of 1.5 × 107 CFU/mL and from day 10 to day 15 at the 1.5 × 105 and 1.5 × 106 CFU/mL doses, at which doses a decrease, more or less significant of inflammatory granulomas surfaces was recorded, suggesting that bacteria were either cleared from the lungs or disseminated (Fig. 4A).

The increase of inflammatory granulomas area of Wistar male rat lung parenchyma after the inoculation during 15 days of dose of 1.5 × 107 CFU/mL of K. pneumoniae ATCC 43816 in this study indicates that bacteria had probably recolonised the parenchyma of lung tissues. For the male rats, the progression of pneumonia following exposure to the same doses wasn’t as homogenous as that observed for the female Wistar rats. However, the transient increase of bacterial loads was associated with moderate macrophage recruitment at bacteria foci on day 5, and the persistence or not of these macrophages up to day 15 post-inoculation highly, would depend on the infecting dose in both sexes.

Impact of pneumonia infection on the body weight evolution

Body weight loss

The lung infection caused by K. pneumoniae ATCC 43816 at 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL doses provoked a significant body weight loss in female rats at day 9 of inoculation for tested groups 1.5 × 106 CFU/mL (p < 0.01) and 1.5 × 107 CFU/mL (p < 0.001). Interestingly, the same evolution from day 2 for 1.5 × 108 CFU/mL (p < 0.001). In contrast, a slight increase in body weight was observed in female rats infected with 1.5 × 105 CFU/mL (Fig. 5B). However, the body weight increase of this female group remained lower than the none-infected control (p < 0.001). For male rats, only the infected groups with 1.5 × 107 and 1.5 × 108 CFU/mL presented a significant decrease (p < 0.001) in body weight from day 10, leading to a body weight loss of 12.5% on day 15 (Fig. 5A).

Fig. 5
figure 5

Body weight evolution of Wistar rats. Status of the percentage of body weight of males (A) and females (B) Wistar rats during K. pneumoniae ATCC 43816 pneumonia induction. All results were mean ± SD of six animals per group. Body weight evolution was analysed using Dunnett’s post-test (*: p < 0.05; **: p < 0.01; ***: p < 0.001); K. pneumoniae ATCC 43816 infected groups at 1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL doses vs not-infected group

Full size image

Inoculated K. pneumoniae doses that resulted in significant weight loss (p < 0.05) in both sexes of Wistar rats were those that also highlighted a regular increase in bacteraemia and/or inflammatory granuloma forming proportional to K. pneumoniae ATCC 43816 infective doses.

Discussion

The pathogenesis of Klebsiella pneumoniae in respiratory tract infections has been widely investigated in several studies [12, 13, 17,18,19]. It is an opportunistic pathogen causing both community-acquired and nosocomial infections [20], ranging from mild urinary tract infections to severe pneumonia with high morbidity and mortality rates [21,22,23]. Various studies have investigated the role of gender on the infectivity of K. pneumoniae or other pneumonic pathogens on animal models of pneumonia, such as mice (Swiss albino, C57BL/6, BALB/c, NMRI, DBA/2, Swiss Webster, etc.) and Sprague Dawley rats [2, 8, 14, 24, 25]. However, previous studies show that these investigations have not been carried out on the Wistar rat model, the experimental model most used for drug discovery studies in tropical areas and, particularly in sub-Saharan Africa due to the ease of this rodent species to acclimating and adapting to environmental conditions.

Especially, the K. pneumoniae strains have been used to induce pneumonia in the sus-mentioned animal models with determinate pathogenic characteristics [2, 12, 26]. However, despite the progress in understanding the pathogenesis of this germ, the preliminary research hasn’t focused on understanding the gender impact on the standardisation of the physiopathogenesis of K. pneumoniae ATCC 43816 in Wistar rats’ model when used for lobar pneumonia induction. Therefore, this study aimed at the sex-dependent vulnerability of Wistar rat’s respiratory tract infection model using intranasal instillation of K. pneumoniae ATCC 43816. Thus, the evaluated parameters in pulmonary tissues and whole blood of K. pneumoniae ATCC 43816-infected groups were significantly pathological when compared to the control group, consistent with findings from previous studies [2, 12,13,14, 27].

Different inoculum doses were evaluated to determine the optimal K. pneumoniae ATCC 43816 dose for inducing pneumonia in Wistar rats without causing death. Among the doses tested (1.5 × 105, 1.5 × 106, 1.5 × 107 and 1.5 × 108 CFU/mL), only the animals inoculated with 1.5 × 108 bacteria/mL showed significant lethality in the female group starting from day 12 of inoculation. The optimal dose for inducing stable lobar pneumonia was found to be 1.5 × 106 CFU/mL for female Wistar rats and 1.5 × 108 CFU/mL for male Wistar rats. Animals receiving these doses exhibited a loss of 10% to 12.5% of their initial body weight, indicating the development of lobar pneumonia. In comparison, Vivek-Kumar et al. reported an optimal infectious dose of 1 × 106 CFU/mL K. pneumoniae MTCC 109 inducing stable pneumonia in a non-specified male rat model [2]. It is interesting to note that while this result approximately equals the optimal dose that we report in this study for female Wistar rats, it’s a hundred lower than the optimal dose we found for male rats.

Determination of the LD50 of K. pneumoniae ATCC 43816 inoculum revealed its infective role in pneumonia induction in both male and female Wistar rats, with a lower LD50 observed in females. It thus appears that K. pneumoniae ATCC 43816 could be more pathogenic and virulent in female rats compared to males. These results align with reports in other previous studies using female C57BL/6 mice inoculated with the pneumonic pathogen W. chondrophila [28, 29]. Further similar results were found in studies using various strains of pneumonic pathogens and experimental animal models [2, 9, 29, 30].

It is worth noting that the intranasal instillation technique used in this study has limitations, such as variability in the volume of lung deposition among different animals testing, as some bacteria may remain in the upper respiratory tract, get exhaled, or end up in the digestive tract. Hence, residual bacteria could be either stay in the upper respiratory tract, exhaled, or deviated into the digestive tract [31]. Interestingly, the same evolution of K. pneumoniae ATCC 43816 load in lung tissues, as attested by Fig. 1C in the male rats depending on the inoculated doses and inoculation time, was similar to that of the females (Fig. 1D), demonstrating the model’s robustness and the reproducibility of this study’s, and highlighting a low variability of K. pneumoniae ATCC 43816 lung deposition. No bacteria were detected in the blood samples of both genders on day 5 post-infection for the lowest doses of 1.5 × 105 and 1.5 × 106 CFU/mL. This could be attributed to bacterial exhalation or the phagocyte action of polymorphonuclear cells like neutrophils and alveolar macrophages recruited to the inflamed lung tissues. In contrast, other studies have reported a significant increase in blood bacterial loads with the same range of doses within 6 h to 1 day post-infection with Gram-negative bacteria, reaching 4.05 log10 to 10 log10 bacteria/mL in blood samples [2, 12, 25].

In response to this infection, we observed that the K. pneumoniae ATCC 43816 proliferation triggers intense inflammation characterized by a disruption of endothelial permeability [30, 32], resulting in purulent fluid release, parenchymal oedema, and a massive influx of polymorphonuclear cells recruited by diapedesis towards the conjunctive inflamed tissues [32]. The gender dependence on K. pneumoniae ATCC 43816-induced pulmonary infection is further elicited by histomorphometry images that we used to obtain a spatiotemporal evaluation of inflammatory granulomas and pulmonary oedema caused by the pathogen’s virulence. Indeed, the appearance, amplification and/or regression of the inflammatory manifestations could be observed through the evolution of granuloma areas and histomorphometry of inflammatory granulomas in pulmonary parenchymas during the inoculation period. The quantification of this pathogenic evolution through the graphic representations of granuloma areas (Figs. 2 and 4), indicated the regression of inflammatory granulomas in male rats receiving the inoculum doses of 1.5 × 105 and 1.5 × 106 CFU/mL on days 15, and 1.5 × 107 CFU/mL on days 10 post-inoculation. However, male rats receiving the highest dose of 1.5 × 108 CFU/mL and females across all doses exhibited more regular, stable temporal and spatial evolution in inflammatory granuloma appearance during K. pneumoniae ATCC 43816 pneumonia, reflecting an aggravation of the pneumonic infection through the inoculation time. These results could be interpreted as an indication of a greater susceptibility of Wistar female rat vis a vis the pathogenicity of K. pneumoniae for the tested infecting doses.

Gender differences in immune function have been well-established in humans and animals [8, 9]. In animal models of respiratory infections, sex has been shown to influence susceptibility and severity of the pneumonia disease, however in inconsistent results [8]. This inconsistency may vary depending on the family or specie of the pneumonic microorganisms used. The results obtained in this study suggest that the examined parameters promoting the pathogenesis of K. pneumoniae ATCC 43816 pneumonia in Wistar rats confirm the gender/sex-hormones duality rule. It’s been shown that the impact of sex on K. pneumoniae pneumonia pathogenesis always aligns with the influence of sex hormones [9, 10]. Furthermore, males generally exhibit weaker humoral and cell-mediated immune responses compared to females as corroborated by a similar report to this study, showing that female mice tend to be more susceptible to lung infection than males in strains of Pseudomonas aeruginosa, a Gram-negative bacteria [33]. Female animals have also been shown to display greater weight loss and significant bacterial load, showing a more vigorous inflammatory response in the lungs than males [8, 33]. However, contrasting results exist showing that male animals could develop more severe inflammatory manifestations than females following pulmonary pathogenic infection. For instance, Carey et al. have shown that male mice develop more severe granulomatous lung lesions than females following infection with Mycobacteria as Mycobacterium marinum or Mycobacteria intracellulare [8].

These contrasting results give an indication of what could guide the relationship between the animal’s gender and the type and character of specific pro-inflammatory responses. Indeed, based on a general tendency, it has been proposed that males generally exhibit weaker humoral and cells mediated immune responses compared to females [9, 34]. During these pro-inflammatory processes, males would produce an acute alveolar inflammatory response, characterised by predominantly neutrophilic infiltration, oedema and haemorrhage. Females, on the other hand, initiate a chronic peribronchial inflammatory response characterised by mononuclear cell and neutrophil infiltration [10, 34]. It has also been shown that sex hormones and their metabolites (e.g. oestrogen, estradiol, estrone, estriol, progesterone) seem to directly or indirectly influence pro-inflammatory processes and host resistance to the infectious agent [9, 10, 34]. Similarly, Fuseini and Newcomb also showed that oestrogens and their metabolites can trigger lung pro-inflammatory, while male hormones, such as testosterone, usually plays the opposite role [35]. In the case of lower respiratory tract infections, specifically by K. pneumoniae pneumonia, these sex hormones induce the overproduction of pro-inflammatory mediators and secretory hyperactivity, which consequently cause aggravation and greater severity of the pathology in female Wistar rats compared to males [9, 33, 34].

Nevertheless, our results show that high infectious doses of K. pneumoniae ATCC 43816 (≥ 1.5 × 108 CFU/mL) would over-rule gender and, humoral and cells-mediated influences, over-activating the immune system by the excessive and uncontrolled recruitment of pro-inflammatory mediators in both males and females and leading to the installation of severe pneumonia.

Finally, in relation to the animals’ body weight changes, this study has found no relationship with the animals’ gender. However, a regular increase in bacteraemia, along with a regular increase in the surface of inflammatory granulomas seemed to be accompanied by an inoculum dose-dependent decrease in the animal’s body weight. These results are corroborated by previous studies by Pilloux et al., showing that female C57BL/6 mice infected with W. chondrophila, showed a significant body weight loss (p < 0.05) along with the appearance and aggravation of the pneumonia disease [14]. Thus, the installation of severe pneumonia induced by K. pneumoniae ATCC 43816 seems to be accompanied by a body weight loss, notwithstanding the animals’ gender.

Conclusion

In summary, the results of this study demonstrate a major difference between the male and the female Wistar rats in the virulence of K. pneumoniae ATCC 43816, reinforcing the importance of studying inflammatory granulomas forming, bacteraemia, and diffuse alveolar damages during the physiopathogenesis of lobar pneumonia taking sex and sex hormones into account. Although having highlighted the formation of inflammatory granulomas and alveolar alterations, the study did not differentiate or quantify the inflammatory markers found in infected tissues. These data also show that in the case of lower respiratory tract infections and especially K. pneumoniae pneumonia, these sex hormones could promote the overproduction of pro-inflammatory mediators characterized by the appearance of secretory hyperactivity and inflammatory granulomas forming in conjunctive tissue of lung parenchyma, which consequently cause the aggravation of the K. pneumoniae pneumonia in female Wistar rats. Considering these results, together with other previous ones, we believe that gender and sex hormones are related to the immune system in a complex manner and influence the pathogenesis of several respiratory tract pathogens, especially K. pneumoniae. Furthermore, the relative information to the vulnerability of the Wistar rat model will enable us to better adjust the pathological parameters in future preclinical trials using this animal model in the treatment of infectious pneumonia.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

K. pneumoniae :

K. pneumoniae ATCC 43816

LD50 :

Lethal dose 50

Log10 :

Decimal logarithm

M/F:

Male/female

PI:

Post-inoculation

PBS:

Phosphate buffered saline

References

  1. Mackenzie G. The definition and classification of pneumonia. Pneumonia. 2016;8:14.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Vivek-Kumar D, Parveen Kumar P, Manu C. Comparative study of CSE 1034 and Ceftriaxone in pneumonia induced rat. Clin Exp Pharmacol. 2012;2(1):1000108.

    Google Scholar 

  3. Sanders NL, Martin IMC, Sharma A, Jones MR, Quinton LJ, Bosmann M, et al. Neutrophil extracellular traps as an exacerbating factor in bacterial pneumonia. Infect Immun. 2022;90:e0049121.

    Article  PubMed  Google Scholar 

  4. Beletew B, Bimerew M, Mengesha A, Wudu M, Azmeraw M. Prevalence of pneumonia and its associated factors among under-five children in East Africa: a systematic review and meta-analysis. BMC Pediatr. 2020;20:254.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Solomon Y, Kofole Z, Fantaye T, Ejigu S. Prevalence of pneumonia and its determinant factors among under-five children in Gamo Zone, southern Ethiopia, 2021. Front Pediatr. 2022;10:1017386. https://doi.org/10.3389/fped.2022.1017386.

    Article  PubMed  PubMed Central  Google Scholar 

  6. OMS (Organisation Mondiale de la Santé). Pneumonia in children. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia.

  7. OMS (Organisation Mondiale de la Santé). Lower respiratory infections. 2023. Available from: https://platform.who.int/mortality/themes/theme-details/topics/indicator-groups/indicator-group-details/MDB/lower-respiratory-infections.

  8. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol-Lung Cell Mol Physiol. 2007;293:L272–8.

    Article  CAS  PubMed  Google Scholar 

  9. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol. 2001;1(6):983–93.

    Article  CAS  PubMed  Google Scholar 

  10. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem. 1990;3535(2):157–72.

    Article  Google Scholar 

  11. Labeda DP. Culture Collections: An Essential Resource for Microbiology. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM, editors. Bergey’s Manual® of Systematic Bacteriology: Volume Two: The Proteobacteria, Part A Introductory Essays. Boston, MA: Springer US; 2005. p. 111–3. https://doi.org/10.1007/0-387-28021-9_13.

  12. Yadav V, Sharma S, Harjai K, Mohan H, Chhibber S. Induction & resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in mice. Indian J Med Res. 2003;118:47–52.

    PubMed  Google Scholar 

  13. Held TK, Mielke ME, Chedid M, Unger M, Trautmann M, Huhn D, et al. Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood. 1998;91:2525–35.

    CAS  PubMed  Google Scholar 

  14. Pilloux L, LeRoy D, Brunel C, Roger T, Greub G. Mouse model of respiratory tract infection induced by Waddlia chondrophila. Plos One. 2016;11:e0150909.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Buttignol M, Pires-Neto RC, Rossi e Silva RC, Albino MB, Dolhnikoff M, Mauad T. Airway and parenchyma immune cells in influenza A(H1N1)pdm09 viral and non-viral diffuse alveolar damage. Respir Res. 2017;18:147.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Haider S, Collingro A, Walochnik J, Wagner M, Horn M. Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients. FEMS Microbiol Lett. 2008;281:198–202.

    Article  CAS  PubMed  Google Scholar 

  17. NCBI (National Center for Biotechnology Information). Klebsiella pneumoniae - MeSH. 1972. Available from: https://www.ncbi.nlm.nih.gov/mesh/68007711

  18. Ni W, Yang D, Guan J, Xi W, Zhou D, Zhao L, et al. In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2021;76(8):2097–105.

    Article  CAS  PubMed  Google Scholar 

  19. Weiss WJ, Pulse ME, Nguyen P, Growcott EJ. In vivo efficacy of novel Monobactam LYS228 in murine models of Carbapenemase-producing Klebsiella pneumoniae infection. Antimicrob Agents Chemother. 2019;63(4):e02214-e2218.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Banu B. Pneumonia. Encyclopedia of Biomedical Gerontology. 2020;48–63. https://doi.org/10.1016/B978-0-12-801238-3.62174-8.

  21. Breathnach AS. Nosocomial infections and infection control. Medicine. 2013;41:649–53.

    Article  Google Scholar 

  22. Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478–82.

    Article  Google Scholar 

  23. Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37:129–34.

    Article  PubMed  Google Scholar 

  24. Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, et al. Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents. Front Microbiol. 2022;13:988728.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chakotiya A, Narula A, Sharma R. Efficacy of methanol extract of Zingiber officinale rhizome against acute pneumonia caused by Pseudomonas aeruginosa. J Lung Health Dis. 2018;2(1):1–8.

    Article  Google Scholar 

  26. Sharma S, Mohan H, Sharma S, Chhibber S. A comparative study of induction of pneumonia in mice with planktonic and biofilm cells of Klebsiella pneumoniae. Microbiol Immunol. 2011;55(5):295–303.

    Article  CAS  PubMed  Google Scholar 

  27. Wu X, Yu C, Cai W, Hua J, Li S, Wang W. Protective effect of a polyphenolic rich extract from Magnolia officinalis bark on influenza virus-induced pneumonia in mice. J Ethnopharmacol. 2011;134(1):191–4.

    Article  CAS  PubMed  Google Scholar 

  28. Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, et al. Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. Plos One. 2011;6(6):e21477.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yang Z-P, Kuo C-C, Grayston JT. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun. 1993;61(5):2037–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jupelli M, Shimada K, Chiba N, Slepenkin A, Alsabeh R, Jones HD, et al. Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis. Plos One. 2013;8(10):e77447.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mizgerd JP, Skerrett SJ. Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol. 2008;294:L387-398.

    Article  CAS  PubMed  Google Scholar 

  32. Tournebize R, Doan BT, Dillies MA, Maurin S, Beloeil JC, Sansonetti PJ. Magnetic resonance imaging of Klebsiella pneumoniae-induced pneumonia in mice. Cell Microbiol. 2006;8(1):33–43.

    Article  CAS  PubMed  Google Scholar 

  33. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, et al. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology. 2002;107(3):297–305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Fuentes N, Silveyra P. Endocrine regulation of lung disease and inflammation. Exp Biol Med (Maywood). 2018;243(17–18):1313–22.

    Article  CAS  PubMed  Google Scholar 

  35. Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19–34.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the “African Centre of Excellence—Centre for Training, Research and Expertise in Drug Sciences” of Joseph Ki-Zerbo University (Ouagadougou; Burkina Faso) through Professor Rasmané Semde for their invaluable training and technical assistance in the realisation of this work. We also thank Professors Ibrahim Sangare and Sakira Abdoul Karim for the huge input and faith they gave us to ameliorate this review writing.

Funding

This research work received no specific grant from any public, commercial, or research funding program.

Author information

Authors and Affiliations

  1. Laboratory of Drug Development, Centre for Training, Research and Expertise in Drug Sciences, Doctoral School of Sciences and Health, University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

    Patrick Hervé Diboue Betote, Raogo Ouedraogo & Rasmané Semde

  2. Laboratory of Pharmacology and Drugs Discovery, Centre for Research On Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies, Yaoundé, Cameroon

    Patrick Hervé Diboue Betote, Sonia Raïssa Gayap Matchuenkam, Sandrine Suzanne Bayengue Beack & Gabriel A. Agbor

  3. Department of Microbiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon

    Patrick Hervé Diboue Betote, Esther Del Florence Ndedi Moni & Maximilienne Ascension Nyegue

  4. Department of Galenical Pharmacy and Pharmaceutical Law, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

    Patrick Hervé Diboue Betote & Nga Nnanga

  5. Laboratory of Pharmaceutical Technology, Centre for Research On Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies, Yaoundé, Cameroon

    Nga Nnanga

  6. Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon

    Rodrigue Fifen

  7. Department of Food Sciences and Technology, Faculty of Agriculture and Veterinary Medicine, University of Buea, Buea, Cameroon

    Sandrine Suzanne Bayengue Beack

Authors
  1. Patrick Hervé Diboue Betote
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esther Del Florence Ndedi Moni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonia Raïssa Gayap Matchuenkam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sandrine Suzanne Bayengue Beack
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rodrigue Fifen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Raogo Ouedraogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriel A. Agbor
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rasmané Semde
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nga Nnanga
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Maximilienne Ascension Nyegue
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PHDB: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition. EDFNM and SSBB: Conceptualization, Investigation, Data curation, Writing – review & editing. SRGM: Resources, Writing – review & editing, Visualization. RF: Methodology, Validation, Formal analysis, Investigation, Resources. RS, RO and GAA: Data curation, Writing – original draft, Writing – review & editing. NN and MAN: Data curation, Writing – review & editing, Visualization, Supervision, Project administration.

Corresponding author

Correspondence to Patrick Hervé Diboue Betote.

Ethics declarations

Ethics approval and consent to participate

The Institutional Animal Ethical Committee of Faculty of Medicine and Biomedical Sciences (University of Yaoundé I – Yaoundé, Cameroon.) approved the animal experiments (Ethical approval ID: 443/UYI/FMSB/VDRC/DAASR/CSD). The procedures were conducted in accordance with this ethical committee guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diboue Betote, P.H., Del Florence Ndedi Moni, E., Matchuenkam, S.R.G. et al. Sex-dependent vulnerability for Wistar rats model following intranasal instillation with Klebsiella pneumoniae ATCC 43816 causing lobar pneumonia. Pneumonia 16, 5 (2024). https://doi.org/10.1186/s41479-024-00126-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41479-024-00126-y

Keywords

Pneumonia

ISSN: 2200-6133

Contact us